Unknown

Dataset Information

0

Synthesis and Antiproliferative Activity of Novel All-Trans-Retinoic Acid-Podophyllotoxin Conjugate towards Human Gastric Cancer Cells.


ABSTRACT: With the purpose of creating a multifunctional drug for gastric cancer treatment, a novel all-trans-retinoic acid (ATRA) conjugate with podophyllotoxin (PPT) was designed and synthesized, and its in vitro antiproliferative activity was evaluated against human gastric cancer cell lines using CCK-8 assay. The conjugate, P-A, exhibited significant anticancer activity against MKN-45 and BGC-823 cells with IC50 values of 0.419 ± 0.032 and 0.202 ± 0.055 ?M, respectively. Moreover, P-A efficiently triggered cell cycle arrest and induced apoptosis in MKN-45 and BGC-823 cells due to modulation of cell cycle arrest- (CDK1, CDK2, CyclinA and CyclinB1) and apoptosis- (cleaved caspase-3, -8 and -9) related proteins, respectively. Further mechanism studies revealed that P-A could increase the expression levels of RAR? and RAR?, and decrease the level of RAR? in MKN-45 and BGC-823 cells. Finally, P-A inhibited the ERK1/2 and AKT signaling in the above two cancer cell lines. More importantly, the underlying mechanisms of P-A were similar to those of precursor PPT but different with the other precursor ATRA. Together, the conjugate P-A was a promising candidate for the potential treatment of human gastric cancer.

SUBMITTER: Zhang L 

PROVIDER: S-EPMC6154554 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis and Antiproliferative Activity of Novel All-Trans-Retinoic Acid-Podophyllotoxin Conjugate towards Human Gastric Cancer Cells.

Zhang Lei L   Wang Jing J   Liu Lai L   Zheng Chengyue C   Wang Yang Y  

Molecules (Basel, Switzerland) 20170417 4


With the purpose of creating a multifunctional drug for gastric cancer treatment, a novel <i>all-trans</i>-retinoic acid (<b>ATRA</b>) conjugate with podophyllotoxin (<b>PPT</b>) was designed and synthesized, and its in vitro antiproliferative activity was evaluated against human gastric cancer cell lines using CCK-8 assay. The conjugate, <b>P-A</b>, exhibited significant anticancer activity against MKN-45 and BGC-823 cells with IC<sub>50</sub> values of 0.419 ± 0.032 and 0.202 ± 0.055 μM, respe  ...[more]

Similar Datasets

| S-EPMC7206372 | biostudies-literature
| S-EPMC6412232 | biostudies-literature
| S-EPMC9181926 | biostudies-literature
| S-EPMC7554701 | biostudies-literature
| S-EPMC4236914 | biostudies-literature
| S-EPMC3954114 | biostudies-literature
| S-EPMC3322846 | biostudies-literature
| 70824 | ecrin-mdr-crc
| S-EPMC1138294 | biostudies-other
| S-EPMC8402917 | biostudies-literature